Allyl 2-(3-(4-butoxybenzoyl)-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Catalog No. :
ACJEUP415
CAS No. :
609796-69-2
Molecular Formula :
C30H30N2O7S
Molecular Weight :
562.64

IUPAC Name:allyl 2-(3-(4-butoxybenzoyl)-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Allyl 2-(3-(4-butoxybenzoyl)-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAllyl 2-(3-(4-butoxybenzoyl)-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
IUPAC Nameallyl 2-(3-(4-butoxybenzoyl)-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
MDL No.MFCD04441198
Molecular FormulaC30H30N2O7S
Molecular Weight562.64
SMILESC=CCOC(=O)C1=C(C)N=C(N2C(=O)C(O)=C(C(=O)C3=CC=C(OCCCC)C=C3)C2C2=CC=C(OC)C=C2)S1
InChI KeyUCVDXBWRNDVTLI-UHFFFAOYSA-N
SynonymALLYL 2-[3-(4-BUTOXYBENZOYL)-4-HYDROXY-2-(4-METHOXYPHENYL)-5-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLATE;SALOR-INT L435333-1EA
CAS No.609796-69-2

Synthetic Route by SureRoute

1. ACJEUP415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEUP415 route product structure diagram
    ACJEUP415609796-69-2
Inquiry

2. ACJEUP415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEUP415 route product structure diagram
    ACJEUP415609796-69-2
Inquiry

Comments (0)